D'AVOLIO, ANTONIO
D'AVOLIO, ANTONIO
SCIENZE MEDICHE
25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2
2020-01-01 D'avolio A.; Avataneo V.; Manca A.; Cusato J.; De Nicolo A.; Lucchini R.; Keller F.; Cantu M.
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
2014-01-01 Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG
A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients
2023-01-01 Sanson, Gianfranco; De Nicolò, Amedeo; Zerbato, Verena; Segat, Ludovica; Koncan, Raffaella; Di Bella, Stefano; Cusato, Jessica; di Masi, Alessandra; Palermo, Andrea; Caironi, Pietro; D'Agaro, Pierlanfranco; Luzzati, Roberto; D'Avolio, Antonio
A Common mdr1 Gene Polymorphism is Associated with Changes in Linezolid Clearance
2018-01-01 Allegra, Sarah; Di Paolo, Antonello; Cusato, Jessica; Fatiguso, Giovanna; Arrigoni, Elena; Danesi, Romano; Corcione, Silvia; D'Avolio, Antonio
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop
2014-01-01 A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy
2022-01-01 Manca, Alessandra; Palermiti, Alice; Mula, Jacopo; De Vivo, Elisa Delia; Zeaiter, Sandra; Simiele, Marco; De Nicolò, Amedeo; Cantù, Marco; Cusato, Jessica; D'Avolio, Antonio
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load
2010-01-01 Calcagno A; Milia MG; D'Avolio A; Ndayishimiyae P; Dusabimana P; Bonora S; Cusato J; Simiele M; Rostagno R; Siccardi M; Audagnotto S; Ghisetti V; Di Perri G.
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
2011-01-01 A. D'Avolio;M. Simiele;M. Siccardi;L. Baietto;M. Sciandra;V. Oddone;F. R. Stefani;S. Agati;J. Cusato;S. Bonora;G. Di Perri
A LC-MS method to quantify tenofovir urinary concentrations in treated patients
2015-01-01 Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients
2008-01-01 Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de; Stefano Bonora; Giovanni Di Perri
A new HPLC method to measure plasma levels of enfuvirtide (ENF or T-20)
2004-01-01 D'Avolio A.; Sciandra M.; Bonora S.; Ibanez A.; Marucco D.; Di Perri G.
A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring
2022-01-01 Manca, Alessandra; Chiara, Francesco; Mula, Jacopo; Palermiti, Alice; Maiese, Domenico; Zeaiter, Sandra; De Nicolo, Amedeo; Imperiale, Daniele; De Filippis, Giacomo; Vischia, Flavio; De Cori, David; Cusato, Jessica; D'Avolio, Antonio
A new UPLC-MS-MS method to quantify first line antituberculosis agents in plasma spotted on dried sample spots device (DSSD)
2015-01-01 L. Baietto; V. Poretti; K. Baruffi; G. Di Perri; A. D'Avolio
A new validated Solid Phase Extraction (SPE)-HPLC method to measure plasma concentrations of tenofovir
2004-01-01 D'Avolio A.; Sciandra M.; Bonora S.; Boffito M.; Canta F.; De Requena D.; Di Perri G.
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring
2022-01-01 Avataneo V.; Fanelli E.; De Nicolo Amedeo.; Rabbia F.; Palermiti A.; Pappaccogli M.; Cusato J.; De Rosa F.G.; D'Avolio A.; Veglio F.
A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis
2021-01-01 Cusato, J; Calcagno, A; Antonucci, M; Marinaro, L; Avataneo, V; De Nicolò, Amedeo; Bonora, S; Di Perri, G; D'avolio, A
A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients.
2008-01-01 Bonora S; D'Avolio A; Tettoni C; Siccardi M; Gonzalez de Requena D; Baietto L; Cometto C; Sciandra M; Trentini L; Di Perri G.
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease
2008-01-01 Giovanni Guaraldi; Stefania Cocchi; Alice Motta; Sara Ciaffi; Mauro Codeluppi; Stefano Bonora; Fabrizio Di Benedetto; Michele Masetti; Marco Floridia; Silvia Baroncelli; Diego Pinetti; Antonio D'Avolio; Alfio Bertolini; Roberto Esposito
A population pharmacokinetic model confirms an association between a pregnane-X-receptor (PXR) polymorphism and unboosted atazanavir clearance
2009-01-01 Schipani A; Siccardi M; D'Avolio A; Baietto L; Calcagno A; Tettoni C; Bonora S; Davis G; Khoo S; Back DJ; Di Perri G; Owen A
A Population Pharmacokinetic Model Illustrates an Association Between a Pregnane-X-Receptor (PXR) Polymorphism and Boosted Atazanavir Clearance
2010-01-01 Schipani A; Siccardi M; Boffito M; D’Avolio A; Bonora S; Davies G; Khoo S; Back D; Di Perri G; Owen A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 | 2020 | D'avolio A.; Avataneo V.; Manca A.; Cusato J.; De Nicolo A.; Lucchini R.; Keller F.; Cantu M. | |
| A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? | 2014 | Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG | |
| A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients | 2023 | Sanson, Gianfranco; De Nicolò, Amedeo; Zerbato, Verena; Segat, Ludovica; Koncan, Raffaella; Di Bella, Stefano; Cusato, Jessica; di Masi, Alessandra; Palermo, Andrea; Caironi, Pietro; D'Agaro, Pierlanfranco; Luzzati, Roberto; D'Avolio, Antonio | |
| A Common mdr1 Gene Polymorphism is Associated with Changes in Linezolid Clearance | 2018 | Allegra, Sarah; Di Paolo, Antonello; Cusato, Jessica; Fatiguso, Giovanna; Arrigoni, Elena; Danesi, Romano; Corcione, Silvia; D'Avolio, Antonio | |
| A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop | 2014 | A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio | |
| A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy | 2022 | Manca, Alessandra; Palermiti, Alice; Mula, Jacopo; De Vivo, Elisa Delia; Zeaiter, Sandra; Simiele, Marco; De Nicolò, Amedeo; Cantù, Marco; Cusato, Jessica; D'Avolio, Antonio | |
| A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load | 2010 | Calcagno A; Milia MG; D'Avolio A; Ndayishimiyae P; Dusabimana P; Bonora S; Cusato J; Simiele M; Rostagno R; Siccardi M; Audagnotto S; Ghisetti V; Di Perri G. | |
| A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. | 2011 | A. D'Avolio;M. Simiele;M. Siccardi;L. Baietto;M. Sciandra;V. Oddone;F. R. Stefani;S. Agati;J. Cusato;S. Bonora;G. Di Perri | |
| A LC-MS method to quantify tenofovir urinary concentrations in treated patients | 2015 | Simiele, Marco; Carcieri, Chiara; DE NICOLO', Amedeo; Ariaudo, Alessandra; Sciandra, Mauro; Calcagno, Andrea; Bonora, Stefano; DI PERRI, Giovanni; D'Avolio, Antonio | |
| A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients | 2008 | Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de; Stefano Bonora; Giovanni Di Perri | |
| A new HPLC method to measure plasma levels of enfuvirtide (ENF or T-20) | 2004 | D'Avolio A.; Sciandra M.; Bonora S.; Ibanez A.; Marucco D.; Di Perri G. | |
| A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring | 2022 | Manca, Alessandra; Chiara, Francesco; Mula, Jacopo; Palermiti, Alice; Maiese, Domenico; Zeaiter, Sandra; De Nicolo, Amedeo; Imperiale, Daniele; De Filippis, Giacomo; Vischia, Flavio; De Cori, David; Cusato, Jessica; D'Avolio, Antonio | |
| A new UPLC-MS-MS method to quantify first line antituberculosis agents in plasma spotted on dried sample spots device (DSSD) | 2015 | L. Baietto; V. Poretti; K. Baruffi; G. Di Perri; A. D'Avolio | |
| A new validated Solid Phase Extraction (SPE)-HPLC method to measure plasma concentrations of tenofovir | 2004 | D'Avolio A.; Sciandra M.; Bonora S.; Boffito M.; Canta F.; De Requena D.; Di Perri G. | |
| A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring | 2022 | Avataneo V.; Fanelli E.; De Nicolo Amedeo.; Rabbia F.; Palermiti A.; Pappaccogli M.; Cusato J.; De Rosa F.G.; D'Avolio A.; Veglio F. | |
| A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis | 2021 | Cusato, J; Calcagno, A; Antonucci, M; Marinaro, L; Avataneo, V; De Nicolò, Amedeo; Bonora, S; Di Perri, G; D'avolio, A | |
| A pilot study evaluating plasma and intracellular pharmacokinetics (PK) of switching from atazanavir (ATV) 400mg QD to ATV 200 mg BID in HIV+ patients. | 2008 | Bonora S; D'Avolio A; Tettoni C; Siccardi M; Gonzalez de Requena D; Baietto L; Cometto C; Sciandra M; Trentini L; Di Perri G. | |
| A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease | 2008 | Giovanni Guaraldi; Stefania Cocchi; Alice Motta; Sara Ciaffi; Mauro Codeluppi; Stefano Bonora; Fabrizio Di Benedetto; Michele Masetti; Marco Floridia; Silvia Baroncelli; Diego Pinetti; Antonio D'Avolio; Alfio Bertolini; Roberto Esposito | |
| A population pharmacokinetic model confirms an association between a pregnane-X-receptor (PXR) polymorphism and unboosted atazanavir clearance | 2009 | Schipani A; Siccardi M; D'Avolio A; Baietto L; Calcagno A; Tettoni C; Bonora S; Davis G; Khoo S; Back DJ; Di Perri G; Owen A | |
| A Population Pharmacokinetic Model Illustrates an Association Between a Pregnane-X-Receptor (PXR) Polymorphism and Boosted Atazanavir Clearance | 2010 | Schipani A; Siccardi M; Boffito M; D’Avolio A; Bonora S; Davies G; Khoo S; Back D; Di Perri G; Owen A |